Issuu on Google+

Cancer Outcomes | 2 0 1 3


Table of Contents 4-10 // Outcomes Data 4 // Brain & CNS (Malignant Only) 5–Year Survival 4 // Breast Cancer 5–Year Survival 5 // Colon Cancer 5–Year Survival 5 // Corpus Uteri 5 –Year Survival 6 // Liver Cancer 5–Year Survival 6 // Lung Cancer 5–Year Survival 7 // Lymphoma Cancer 5–Year Survival 7 // Melanoma of the Skin 5–Year Survival 8 // Ovarian Cancer 5–Year Survival 8 // Pancreas Cancer 5–Year Survival 9 // Prostate Cancer 5–Year Survival 12 // Colorado’s Only Federally Designated Cancer Center


University of Colorado Hospital

is the leading academic medical center in the nation. University of Colorado Hospital (UCH) is recognized as the highest-performing academic hospital in the United States for delivering quality health care by the University HealthSystem Consortium for two years in a row, and is ranked as the best hospital in the Denver metro area and one of the best in the country by U.S. News & World Report. UCH is best known as an innovator in patient care and often is one of the first hospitals to bring new medicine to the patient’s bedside. The hospital’s physicians are affiliated with the University of Colorado School of Medicine, part of the University of Colorado system. Based at the expansive Anschutz Medical Campus in Aurora, Colo., UCH is where patient care, research and education converge to establish the future of health care delivery.

3


13%

Prostate Cancer - 5 Year Survival 10% 10%

OUTCOMES data 93%

94%

84% 83%

Stage I*

UCH

95% 92% 91% 4% 3% 0%

89% 91%

Stage II

KEY

UCH

Colorado

State National National 3% 2% 2% observed survival data 2003-2006 (AJCC 6th Edition) Stage IV 45% 36% 38%

Stage III

*n=18

Brain & CNS (Malignant Only) 5–Year Survival

Brain & CNS (Malignant Only) - Survival by Year 73%

Stage I 58% 52%

61%

Stage II

54%

93% 90% 91%

47% 36% 37%

30%

34%

UCH 69% 68% 66%

Year 1

Year 2

58% 60% Year 3

77%II Stage

25% National

State

54% Year 4

Year 5

Lymphoma - 5 Year Survival 83% 79% Stage I

State National Stage IV

49%

45%

Melanoma of the Skin - 5 Year 36% Survival 38%

UCH

Stage III

11% 10% 13% 77% Stage III

UCH

State National Stage IV

Breast Cancer 5–Year Survival

Breast Cancer - 5 Year Survival 96%

92% 92%

92%

UCH

86% 85% 75% 62%

State

National

67% 41% 26%

Stage I

Stage II

Lung Cancer - 5 Year Survival

4

Stage III

21%

Stage IV


68% 66%

38% 37%

83%

79%

74%

Stage I

73%

77%

73%

Stage II*

77%

70%

33%

UCH20%State National 17% 15% 61%

53% 52% 50% Stage IV

Stage III

*n  =  14

Colon Cancer 5–Year Survival Colon Cancer - 5 Year Survival 88% 74% I78% Stage

*n=  18

II 69%Stage 67% 67%

Liver Cancer - 5 Year Survival 52%

48% 35% 33% Stage I

*n  =  22

Stage III* 64% 55% 49%

UCH

UCH

Stage II 25% 26%

*N = 22

National 9% 10%

Stage IV

14% 4%

Stage II

23% State

Stage III*

14%

Stage I

State National Stage IV

6%

2%

Stage III

2%

Stage IV

Corpus Uteri 5–Year Survival Corpus Uteri - 5 Year Survival 88% 89% 88%

82%

76% 73%

74%

UCH

State

National

67% 53%

25%

Stage I

Stage II

Stage III

17% 16%

Stage IV*

*n  =  20 *N = 20

Ovarian Cancer - 5 Year Survival 94%

89% 85%

84%

UCH

State

National

68% 66% 5


61%

53% 52% 50% UCH

KEY

OUTCOMES data

Colorado National

Stage I

Stage II

Stage III*

Stage IV

observed survival data 2003-2006 (AJCC 6th Edition)

*n=  18

Liver Cancer 5–Year Survival

Liver Cancer - 5 Year Survival 52%

48%

UCH

State

National

35% 33% 25% 26% 14%

14% 4%

Stage I

Stage II

6%

2%

Stage III

2%

Stage IV

Corpus Uteri - 5 Year Survival 88% 89% 88%

82%

76% 73%

74%

UCH

State

National

67% 53%

Lung Cancer 5–Year Survival

Lung Cancer - 5 Year Survival 56% 56%

25% UCH State National 17% 16%

46% 45% 36%

Stage I

*n  =  20

31% Stage II 26%

Stage III

Stage IV*

18%

Ovarian Cancer - 5 Year Survival 94%

89% 85%

Stage I

11% 11%

84% Stage II 68% 66%

Stage III

7%

UCH

3%

2%

State National Stage IV

Pancreas Cancer - 5 Year Survival 22%

6

20% 20%

UCH

13% 10% 10%

State

National


Lymphoma 5–Year Survival 83% 79%

74%

77%

73%

73%

77%

UCH 70%

61%

84% 83%

94%

Stage I

*n=  18

89% 91%

Stage II

95% 92% 91%

National

53% 52% 50%

Prostate Cancer - 5 Year Survival 93%

State

UCH

Stage III*

State

National

Stage IV 45% 36% 38%

*N = 18

Liver Cancer - 5 Year Survival 52%

Stage I

48%

Stage II

Stage III

UCH

State National Stage IV

35% 33% Melanoma of the Skin 5 –Year Survival

Melanoma of the Skin - 5 Year Survival 26% 25%

93% 90% 91%

UCH14%State

14%

69% 68% 66%

Stage I

Stage II

4% 58% 60%

6%

2%

54%

Stage III

82%

76% 73% Stage II

Stage I

2%

Stage IV

Corpus Uteri - 5 Year Survival 88% 89% 88%

National

11% 10% 13% 74%Stage III 67%

UCH

State National Stage IV

53%

Breast Cancer - 5 Year Survival 96%

92% 92%

92%

25% UCH State National 17% 16%

86% 85% 75%

Stage I

*n  =  20

Stage II

67% 62% Stage III

Stage IV*

7


UCH

KEY

OUTCOMES data

Colorado National

observed survival data 2003-2006 (AJCC 6th Edition)

Ovarian 5–Year Survival

Ovarian Cancer - 5 Year Survival 94%

89% 85%

84%

UCH

State

National

68% 66%

Lung Cancer - 5 Year Survival

38% 37%

56%

33% 20% 17% UCH State National 15%

46% 45% 36% 31%II* Stage 26%

Stage I

Stage III

*N = 14

Stage IV

18% 11% 11%

Stage I

Stage II

7%

Stage III

3%

2%

Stage IV

Pancreas Cancer 5–Year Survival Pancreas Cancer - 5 Year Survival 22%

20% 20%

UCH

State

National

13% 10% 10% 4%

3%

3%

0% Stage I*

*n=18

Stage II

Stage III

2%

2%

Stage IV

*N = 18

Brain & CNS (Malignant Only) - Survival by Year 73% 58% 8

UCH

61%

54%

52% 45% 36%

49% 38% 30%

State

National

47% 36% 37%

34%


Prostate Cancer 5–Year Survival Prostate Cancer - 5 Year Survival 93%

84% 83%

94%

89% 91%

95% 92% 91%

UCH

State

45%

Stage I

Stage II

Stage III

National

36% 38%

Stage IV

*N = 16

Melanoma of the Skin - 5 Year Survival 93% 90% 91%

UCH 69% 68% 66%

58% 60%

State

National

54%

11% 10% 13% Stage I

Stage II

Stage III

Stage IV

Breast Cancer - 5 Year Survival 96%

92% 92%

92%

UCH

86% 85% 75% 62%

State

National

67% 41% 26%

21% 9

Stage I

Stage II

Stage III

Stage IV


NCI CANCER CENTERS IN THE USA

= NCI Cancer Center = NCI Comprehensive Cancer Center = UCH, NCI Comprehensive Cancer Center

Colorado’s only federally designated cancer center tackles cancer from all angles The University of Colorado Cancer Center is the hub of cancer research in Colorado. We are a consortium of more than 400 researchers and physicians at three state universities and six institutions, all working toward one goal: translating science into cancer survivorship.

10


Through collaboration and innovation, CU Cancer Center

Cancer survivorship. We’re one of eight LIVESTRONG Cancer

members discover, develop and deliver breakthroughs that improve

Survivorship Centers of Excellence and home to the region’s

cancer care for people and companion animals. We focus on:

three full-scale cancer survivorship clinics: The HOPE clinic for

Personalized care that embraces the best clinical practices of prevention, diagnosis, treatment and survivorship.

young adult survivors of cancer at Children’s Hospital Colorado, the TACTIC clinic for adult survivors of childhood cancer at University of Colorado Hospital, and the THRIVE clinic for

• Innovative interdisciplinary research.

transitioning adult cancer patients back to primary care.

• Premier clinical and scientific training.

Cancer screening. The Colorado Colorectal Screening Program

• Creative partnerships.

certain financial and risk criteria receive colon cancer screening

Founded in 1988, CU Cancer Center is the only comprehensive cancer center designated by the National Cancer Institute in Colorado and the Rocky Mountain region. Our founding director, Paul A. Bunn, Jr., MD, led the organization until 2009. In 2010, Dan Theodorescu, MD, PhD, ushered CU Cancer Center into a new era. CU Cancer Center is headquartered on the Anschutz Medical Campus in Aurora, Colo., in the University of Colorado School of Medicine. Affiliated institutions include University of Colorado Denver, University of Colorado Boulder, Colorado State University (including its Flint animal cancer center), University of Colorado Health, Children’s Hospital Colorado, Denver Veterans Affairs Medical Center, Denver Health, National Jewish Health and the Kaiser Permanente’s Institute of Health Research. Our clinical outreach program extends throughout Colorado and

is a national model for ensuring uninsured Coloradans who meet and follow-up care at no cost to them. Molecular tumor testing. CU Cancer Center has developed tests that find specific gene defects that can be targeted with new drugs. These tests have positioned CU Cancer Center as a national leader for clinical trials of “targeted” drugs. Cancer clinical trials. CU Cancer Center’s Phase I Trials program is the only program of its kind in the region and nationally recognized. In addition, with the largest number of human cancer clinicals in the region, CU Cancer Center provides patients across the state and region with access to cutting-edge cancer care. Structural biology. CU Cancer Center’s NMR spectroscopy and X-ray facilities are among the best in the world and have helped recruit world-class scientists to use them. The machines, housed

neighboring states.

in CU Cancer Center’s Structural Biology shared resource, help

HIGHLIGHTS AND ACCOMPLISHMENTS

with precise molecular targeting.

CU Cancer Center is known clinically for its personalized cancer

Animal Cancer Center is the world leader in research and

treatments and robust and diverse clinical research and trials

treatment of spontaneously occurring cancers in companion

program and. Our scientific expertise ranges from understanding

animals, especially dogs. CU Cancer Center’s members at CSU

how chromosome structure controls cancer cell behavior, to

collaborate with researchers in human cancers, and clinical trials

understanding how the immune system impacts cancer to carrying

in dogs have led to new treatments for people.

scientists solve structures of cancer molecules to develop drugs

Animal cancer treatment. The Colorado State University Flint

out Phase I trials that bring new therapies to market. Other strengths include: NCCN member. The CU Cancer Center is a member of the National Comprehensive Cancer Network, an alliance of 23 of the world’s leading cancer centers dedicated to improving the quality, effectiveness and efficiency of care provided to patients with cancer. Lung cancer care and research. CU Cancer Center is one of the world’s best lung cancer research and treatment programs. We are the coordinating center for the Lung Cancer Mutations Consortium, funded by a $5.3 million American Reinvestment and

LEARN MORE: www.coloradocancercenter.org www.uch.edu coloradocancerblogs.org facebook.com/coloradocancercenter

Recovery Act Grand Opportunities grant. 11



Cancer Outcomes 2013 - University of Colorado Hospital